Why is CGON Down Today?
About CG Oncology, Inc. Common stock
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically de...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -3.4%
Market Comparison
🔔 Get CGON Alerts
We'll notify you when CGON's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
CGON has moved more than 3.0% down on 37 occasions in the past year.
Frequently Asked Questions
Why is CGON stock down today?
This appears to be a sector-wide move. The BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector is down 3.4% on average.
Is CGON stock a buy or sell right now?
Based on current analysis, CGON shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the CGON stock price target?
CGON is currently trading at $70.32. Based on today's momentum, the expected short-term range is $68.21 - $71.73. See long-term price prediction →
Will CGON stock continue falling?
Our analysis shows a 45% probability that CGON's move continues in the next 1-3 days. Key level to watch: $66.80 (support).
Is CGON stock oversold or overbought?
CGON's RSI (Relative Strength Index) is currently at 55.2. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for CGON stock?
CGON's 10-day momentum indicator is at 6.68. Strong bullish momentum - the stock is gaining significant upward force. This often precedes continued gains.
Is CGON outperforming or underperforming the market?
CGON (-3.15%) is currently significantly underperforming the market (-2.8% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for CGON?
CGON's MACD (1.51) is currently above the signal line (0.26), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 24.7) is moderate.
Is CGON in an uptrend or downtrend?
Based on moving average analysis, CGON is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $65.47, 50-day SMA: $68.04.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis